Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

By | January 19, 2022
Individuals living with type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence.